Breaking the Data Silos | Solving EPCIS Format Disparities in Global Supply Chains
In an ideal world, the pharmaceutical supply chain would operate as a seamless network where product data flows effortlessly between trading partners. After all, that was the promise of EPCIS (Electronic Product Code Information Services) – a global GS1 standard designed to enable disparate applications to create and share visibility event data within and across enterprises.
Yet the reality facing pharmaceutical manufacturers, distributors, and dispensers today is starkly different. Despite operating under the same EPCIS "standard," organizations find themselves trapped in data silos created by proprietary interpretations of these standards.
When Standards Aren't Standard
The EPCIS framework was developed to serve as a universal language for supply chain events. However, as major solution providers implemented the standard, critical differences emerged in their interpretations, creating a fragmented landscape.
These differences manifest in various ways – from schema variations and event structure discrepancies to version interpretation differences. What should have been simple data exchange between partners became a complex translation exercise requiring custom mappings, transformation logic, and continual support & maintenance.
The Business Impact of Fragmentation
For pharmaceutical companies, these EPCIS disparities create tangible business challenges:
- Extended partner onboarding times, often taking weeks or months instead of days
- Increased IT costs from maintaining multiple systems and transformation logic
- Delayed compliance reporting with regulations like US DSCSA and EU FMD due to data exchange issues
- Limited visibility into the end-to-end supply chain, with data locked in incompatible systems
- Missed analytics opportunities from inability to consolidate and analyze data
A mid-sized pharmaceutical manufacturer typically interacts with dozens of trading partners, each potentially using different systems with unique EPCIS interpretations. This multiplies the complexity exponentially, creating an unsustainable burden of custom integrations.
Bridging the Gap with Intelligent Data Exchange
Solving this challenge requires moving beyond point-to-point integrations to a more sophisticated approach. Modern supply chain visibility platforms are addressing these disparities through intelligent data exchange layers that act as universal translators between different EPCIS implementations.
The most effective solutions share several key characteristics:
- Native format understanding – comprehending the nuances of each major EPCIS implementation without requiring custom mapping
- Data lineage preservation – maintaining the integrity and provenance of data as it moves between systems
- Real-time translation – converting between formats without batch delays or information loss
- Adaptive learning – continuously improving mapping capabilities as new format variations emerge
By implementing such solutions, pharmaceutical companies can break down data silos while preserving their investments in existing systems.
The Path Forward
As global pharmaceutical supply chains grow increasingly complex and regulations more stringent, the industry can no longer afford the inefficiencies of fragmented data exchange. The path forward lies not in forcing standardization – a nearly impossible task given the diverse pre-installed systems – but in creating intelligent intermediation that embraces diversity while enabling seamless data exchange.
Organizations that solve this EPCIS inconsistency challenge gain more than just simplified compliance. They unlock the true potential of their serialization data: end-to-end visibility, powerful analytics, and the agility to respond to market changes and evolving global regulations.
In a world where supply chain resilience has become a strategic imperative, breaking down these data silos isn't just a technical necessity – it's a business advantage that separates industry leaders from those struggling to keep pace.
Request a demo today to discover how AltiusHub outruns the “legacy” of the legacy track & trace systems that promised agility but delivered rigidity. The world is transforming at unprecedented speed. Are you and your systems keeping up with the pace?
.webp)
Frequently asked questions
EPCIS is the GS1 global standard for capturing and sharing supply chain events. Pharma implementations differ because vendors interpret event structures, CBV vocabularies, and version nuances differently , creating fragmentation that requires custom integration mappings and transformation logic for different trading partners.
EPCIS implementation inconsistency causes long partner onboarding cycles, repeated integration work, elevated IT and validation costs, and delayed regulatory reporting. When events fail to exchange correctly between systems, missed submission windows and unconfirmed delivery records accumulate into compliance gaps.
EPCIS compliance software for pharma bridges data silos through an intelligent translation layer that automatically maps variant EPCIS structures, converts between versions (1.0, 1.2, 2.0), and preserves event data lineage without requiring a custom integration rebuild for each new trading partner or version change.
Enforcing the GS1 EPCIS 2.0 standard is difficult because trading partners use diverse serialization systems spanning EPCIS 1.0, 1.2, and 2.0, installed across many years. Many partners remain on 1.2 XML. Migrating to EPCIS 2.0 JSON requires coordinated action across hundreds of supply chain participants simultaneously.
An EPCIS integration software translation layer sits between supply chain systems and handles the format and schema differences that exist between EPCIS implementations automatically. Rather than relying on static partner-specific mappings that must be manually rebuilt when anything changes, an intelligent translation layer interprets incoming EPCIS structures dynamically.
Meanwhile, read our top resources
